Exploring the Gut Microbiome in Myasthenia Gravis

The human gut microbiota is vital for maintaining human health in terms of immune system homeostasis. Perturbations in the composition and function of microbiota have been associated with several autoimmune disorders, including myasthenia gravis (MG), a neuromuscular condition associated with varyin...

Full description

Saved in:
Bibliographic Details
Main Authors: Thye, Angel Yun-Kuan, Law, Jodi Woan-Fei, Tan, Loh Teng-Hern, Thurairajasingam, Sivakumar, Chan, Kok-Gan, Letchumanan, Vengadesh, Lee, Learn-Han
Format: Article
Published: MDPI 2022
Subjects:
Online Access:http://eprints.um.edu.my/42943/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.42943
record_format eprints
spelling my.um.eprints.429432023-09-29T03:08:44Z http://eprints.um.edu.my/42943/ Exploring the Gut Microbiome in Myasthenia Gravis Thye, Angel Yun-Kuan Law, Jodi Woan-Fei Tan, Loh Teng-Hern Thurairajasingam, Sivakumar Chan, Kok-Gan Letchumanan, Vengadesh Lee, Learn-Han QH Natural history QH301 Biology QR Microbiology The human gut microbiota is vital for maintaining human health in terms of immune system homeostasis. Perturbations in the composition and function of microbiota have been associated with several autoimmune disorders, including myasthenia gravis (MG), a neuromuscular condition associated with varying weakness and rapid fatigue of the skeletal muscles triggered by the host's antibodies against the acetylcholine receptor (AChR) in the postsynaptic muscle membrane at the neuromuscular junction (NMJ). It is hypothesized that perturbation of the gut microbiota is associated with the pathogenesis of MG. The gut microbiota community profiles are usually generated using 16S rRNA gene sequencing. Compared to healthy individuals, MG participants had an altered gut microbiota's relative abundance of bacterial taxa, particularly with a drop in Clostridium. The microbial diversity related to MG severity and the overall fecal short-chain fatty acids (SCFAs) were lower in MG subjects. Changes were also found in terms of serum biomarkers and fecal metabolites. A link was found between the bacterial Operational Taxonomic Unit (OTU), some metabolite biomarkers, and MG's clinical symptoms. There were also variations in microbial and metabolic markers, which, in combination, could be used as an MG diagnostic tool, and interventions via fecal microbiota transplant (FMT) could affect MG development. Probiotics may influence MG by restoring the gut microbiome imbalance, aiding the prevention of MG, and lowering the risk of gut inflammation by normalizing serum biomarkers. Hence, this review will discuss how alterations of gut microbiome composition and function relate to MG and the benefits of gut modulation. MDPI 2022-04 Article PeerReviewed Thye, Angel Yun-Kuan and Law, Jodi Woan-Fei and Tan, Loh Teng-Hern and Thurairajasingam, Sivakumar and Chan, Kok-Gan and Letchumanan, Vengadesh and Lee, Learn-Han (2022) Exploring the Gut Microbiome in Myasthenia Gravis. Nutrients, 14 (8). ISSN 2072-6643, DOI https://doi.org/10.3390/nu14081647 <https://doi.org/10.3390/nu14081647>. 10.3390/nu14081647
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic QH Natural history
QH301 Biology
QR Microbiology
spellingShingle QH Natural history
QH301 Biology
QR Microbiology
Thye, Angel Yun-Kuan
Law, Jodi Woan-Fei
Tan, Loh Teng-Hern
Thurairajasingam, Sivakumar
Chan, Kok-Gan
Letchumanan, Vengadesh
Lee, Learn-Han
Exploring the Gut Microbiome in Myasthenia Gravis
description The human gut microbiota is vital for maintaining human health in terms of immune system homeostasis. Perturbations in the composition and function of microbiota have been associated with several autoimmune disorders, including myasthenia gravis (MG), a neuromuscular condition associated with varying weakness and rapid fatigue of the skeletal muscles triggered by the host's antibodies against the acetylcholine receptor (AChR) in the postsynaptic muscle membrane at the neuromuscular junction (NMJ). It is hypothesized that perturbation of the gut microbiota is associated with the pathogenesis of MG. The gut microbiota community profiles are usually generated using 16S rRNA gene sequencing. Compared to healthy individuals, MG participants had an altered gut microbiota's relative abundance of bacterial taxa, particularly with a drop in Clostridium. The microbial diversity related to MG severity and the overall fecal short-chain fatty acids (SCFAs) were lower in MG subjects. Changes were also found in terms of serum biomarkers and fecal metabolites. A link was found between the bacterial Operational Taxonomic Unit (OTU), some metabolite biomarkers, and MG's clinical symptoms. There were also variations in microbial and metabolic markers, which, in combination, could be used as an MG diagnostic tool, and interventions via fecal microbiota transplant (FMT) could affect MG development. Probiotics may influence MG by restoring the gut microbiome imbalance, aiding the prevention of MG, and lowering the risk of gut inflammation by normalizing serum biomarkers. Hence, this review will discuss how alterations of gut microbiome composition and function relate to MG and the benefits of gut modulation.
format Article
author Thye, Angel Yun-Kuan
Law, Jodi Woan-Fei
Tan, Loh Teng-Hern
Thurairajasingam, Sivakumar
Chan, Kok-Gan
Letchumanan, Vengadesh
Lee, Learn-Han
author_facet Thye, Angel Yun-Kuan
Law, Jodi Woan-Fei
Tan, Loh Teng-Hern
Thurairajasingam, Sivakumar
Chan, Kok-Gan
Letchumanan, Vengadesh
Lee, Learn-Han
author_sort Thye, Angel Yun-Kuan
title Exploring the Gut Microbiome in Myasthenia Gravis
title_short Exploring the Gut Microbiome in Myasthenia Gravis
title_full Exploring the Gut Microbiome in Myasthenia Gravis
title_fullStr Exploring the Gut Microbiome in Myasthenia Gravis
title_full_unstemmed Exploring the Gut Microbiome in Myasthenia Gravis
title_sort exploring the gut microbiome in myasthenia gravis
publisher MDPI
publishDate 2022
url http://eprints.um.edu.my/42943/
_version_ 1781704659472220160
score 13.2014675